POC Molecular Diagnostics Market to grow by USD 1.83 Bn; Abbott Laboratories, Becton Dickinson and Co., binx Health Inc. emerge as key vendors - Technavio

News provided by

Nov 14, 2022, 17:05 ET

NEW YORK, Nov. 14, 2022 /PRNewswire/ -- The global POC molecular diagnostics market research report provides a detailed analysis of the emerging market trends, regional outlook, competitive landscape, and a comprehensive analysis of different market segments. The report provides a detailed analysis of the market overview, market drivers, opportunities, and potential applications. The POC molecular diagnostics market size is expected to grow by USD 1.83 billion from 2021 to 2026, progressing at a CAGR of 14.67% during the forecast period. View a Free Sample Report Here

Technavio has announced its latest market research report titled Global POC Molecular Diagnostics Market 2022-2026

Key Players Covered in POC Molecular Diagnostics Market Study:

Abbott Laboratories: The company offers portable, rapid molecular ID NOW COVID-19 test that allows fast diagnosis with results in 13 minutes or less in a variety of locations such as point-of-care locations.
Co-Diagnostics Inc.: The company offers a range of real time PCR kits for accurate simultaneous detection of infectious agents involved in respiratory diseases
F. Hoffmann La Roche Ltd.: The company offers point-of-care tests for glucose, urine albumin, and HbA1c as well as total and differential white blood cell count.
genedrive plc: The company delivers robust, connected, and easy-to-use point-of-care solutions.
QuantuMDx Group Ltd.: The company offers a comprehensive portfolio of SARS-CoV-2 testing solutions.
Becton Dickinson and Co.
binx Health Inc.
Danaher Corp.
Lucira Health Inc.
Molbio Diagnostics Pvt. Ltd.
Gain access to detailed vendor profiles. Buy Now!

POC Molecular Diagnostics Market Split by Product

Based on the product, the market is analyzed across segments such as PCR and microarray and hybridization. PCR products not only identify the genetic material of the infection-causing microorganism but can also identify the gene mutations. Therefore, they are widely used in oncology, prenatal, hematology, and endocrinology applications. POC molecular diagnostic products by the PCR technology are highly sensitive and specific, which facilitates the provision of rapid test results. A significant aspect driving segment growth is the rising desire for personalized and precise treatment.

POC Molecular Diagnostics Market Split by Application

By application, the market is analyzed across segments such as infectious diseases, oncology, hematology and endocrinology, and others. The market growth in the infectious diseases segment will be significant over the forecast period. The high incidence of infectious diseases has increased the demand for diagnostic tests and new reagents in the market. Infectious diseases are more prevalent in emerging countries when compared with developed nations. Infectious diseases can be tested in laboratories. However, laboratory tests are lengthy, increasing the period to identify the disease. As a result, many companies are manufacturing POC molecular diagnostic products that can detect the molecular levels such as RNA fragments of the virus and provide rapid results.

The POC molecular diagnostics market will be affected by the growing focus on technological advances. Apart from this, market trends such as the presence of government funding and the growing number of cancer cases worldwide will have a positive impact on the growth of the market.

Identify potential segments to invest in over the forecast period. Download Free Sample Report Now

Imperative Insights on the following aspects:

What was the size of the global POC molecular diagnostics industry by value in 2021?
What will be the size of the global POC molecular diagnostics industry in 2026?
What factors are affecting the strength of competition in the global POC molecular diagnostics industry?
How has the industry performed over the last five years?
What are the main segments that make up the global POC molecular diagnostics market?

Why buy?

Identify growth Strategies across markets
Analyze your competitor market
Get a Holistic View of the Market

Related Reports:

The POC hematology diagnostics market share is expected to reach an estimated USD 1.46 billion by 2026 at an accelerating CAGR of 9.06%. The increasing prevalence of blood disorders and infectious diseases is notably driving the POC hematology diagnostics market growth, although factors such as the high cost of hematology diagnostic products may impede the market growth.
The helicobacter pylori diagnostics market share is expected to increase by USD 209.59 million from 2020 to 2025, and the market's growth momentum will accelerate at a CAGR of 8.1%. The rising prevalence of the disease is notably driving the helicobacter pylori diagnostics market growth, although factors such as competitive pricing pressure may impede the market growth.

POC Molecular Diagnostics Market Scope
Report Coverage	Details
Page number	120
Base year	2021
Forecast period	2022-2026
Growth momentum & CAGR	Accelerate at a CAGR of 14.67%
Market growth 2022-2026	USD 1.83 billion
Market structure	Fragmented
YoY growth (%)	10.4
Regional analysis	North America, Europe, Asia, and Rest of World (ROW)
Performing market contribution	North America at 44%
Key consumer countries	US, Canada, Germany, France, and China
Competitive landscape	Leading companies, competitive strategies, consumer engagement scope
Companies profiled	Abbott Laboratories, Becton Dickinson and Co., binx Health Inc., Co-Diagnostics Inc., Danaher Corp., F. Hoffmann La Roche Ltd., genedrive plc, Lucira Health Inc., Molbio Diagnostics Pvt. Ltd., OraSure Technologies Inc., QIAGEN NV, QuantuMDx Group Ltd., Randox Laboratories Ltd., Robert Bosch GmbH, Siemens AG, Sysmex Corp., Talis Biomedical Corp., Thermo Fisher Scientific Inc., bioMerieux SA, and Quidel Corp.
Market Dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, and market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

Table of Content:

1 Executive Summary

1.1 Market overview

Exhibit 01: Executive Summary – Chart on Market Overview
Exhibit 02: Executive Summary – Data Table on Market Overview
Exhibit 03: Executive Summary – Chart on Global Market Characteristics
Exhibit 04: Executive Summary – Chart on Market by Geography
Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
Exhibit 07: Executive Summary – Chart on Incremental Growth
Exhibit 08: Executive Summary – Data Table on Incremental Growth
Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem

Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition

Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis

Exhibit 13: Market segments

3.3 Market size 2021

3.4 Market outlook: Forecast for 2021-2026

Exhibit 14: Chart on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 15: Data Table on Global - Market size and forecast 2021-2026 ($ million)
Exhibit 16: Chart on Global Market: Year-over-year growth 2021-2026 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

4.1 Five forces summary

Exhibit 18: Five forces analysis - Comparison between2021 and 2026

4.2 Bargaining power of buyers

Exhibit 19: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

4.3 Bargaining power of suppliers

Exhibit 20: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

4.4 Threat of new entrants

Exhibit 21: Threat of new entrants – Impact of key factors in 2021 and 2026

4.5 Threat of substitutes

Exhibit 22: Threat of substitutes – Impact of key factors in 2021 and 2026

4.6 Threat of rivalry

Exhibit 23: Threat of rivalry – Impact of key factors in 2021 and 2026

4.7 Market condition

Exhibit 24: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Product

5.1 Market segments

Exhibit 25: Chart on Product - Market share 2021-2026 (%)
Exhibit 26: Data Table on Product - Market share 2021-2026 (%)

5.2 Comparison by Product

Exhibit 27: Chart on Comparison by Product
Exhibit 28: Data Table on Comparison by Product

5.3 PCR - Market size and forecast 2021-2026

Exhibit 29: Chart on PCR - Market size and forecast 2021-2026 ($ million)
Exhibit 30: Data Table on PCR - Market size and forecast 2021-2026 ($ million)
Exhibit 31: Chart on PCR - Year-over-year growth 2021-2026 (%)
Exhibit 32: Data Table on PCR - Year-over-year growth 2021-2026 (%)

5.4 Microarray and hybridization - Market size and forecast 2021-2026

Exhibit 33: Chart on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
Exhibit 34: Data Table on Microarray and hybridization - Market size and forecast 2021-2026 ($ million)
Exhibit 35: Chart on Microarray and hybridization - Year-over-year growth 2021-2026 (%)
Exhibit 36: Data Table on Microarray and hybridization - Year-over-year growth 2021-2026 (%)

5.5 Market opportunity by Product

Exhibit 37: Market opportunity by Product ($ million)

6 Market Segmentation by Application

6.1 Market segments

Exhibit 38: Chart on Application - Market share 2021-2026 (%)
Exhibit 39: Data Table on Application - Market share 2021-2026 (%)

6.2 Comparison by Application

Exhibit 40: Chart on Comparison by Application
Exhibit 41: Data Table on Comparison by Application

6.3 Infectious diseases - Market size and forecast 2021-2026

Exhibit 42: Chart on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 43: Data Table on Infectious diseases - Market size and forecast 2021-2026 ($ million)
Exhibit 44: Chart on Infectious diseases - Year-over-year growth 2021-2026 (%)
Exhibit 45: Data Table on Infectious diseases - Year-over-year growth 2021-2026 (%)

6.4 Oncology - Market size and forecast 2021-2026

Exhibit 46: Chart on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 47: Data Table on Oncology - Market size and forecast 2021-2026 ($ million)
Exhibit 48: Chart on Oncology - Year-over-year growth 2021-2026 (%)
Exhibit 49: Data Table on Oncology - Year-over-year growth 2021-2026 (%)

6.5 Hematology and endocrinology - Market size and forecast 2021-2026

Exhibit 50: Chart on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
Exhibit 51: Data Table on Hematology and endocrinology - Market size and forecast 2021-2026 ($ million)
Exhibit 52: Chart on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)
Exhibit 53: Data Table on Hematology and endocrinology - Year-over-year growth 2021-2026 (%)

6.6 Others - Market size and forecast 2021-2026

Exhibit 54: Chart on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 55: Data Table on Others - Market size and forecast 2021-2026 ($ million)
Exhibit 56: Chart on Others - Year-over-year growth 2021-2026 (%)
Exhibit 57: Data Table on Others - Year-over-year growth 2021-2026 (%)

6.7 Market opportunity by Application

Exhibit 58: Market opportunity by Application ($ million)

7 Customer Landscape

7.1 Customer landscape overview

Exhibit 59: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape

8.1 Geographic segmentation

Exhibit 60: Chart on Market share by geography 2021-2026 (%)
Exhibit 61: Data Table on Market share by geography 2021-2026 (%)

8.2 Geographic comparison

Exhibit 62: Chart on Geographic comparison
Exhibit 63: Data Table on Geographic comparison

8.3 North America - Market size and forecast 2021-2026

Exhibit 64: Chart on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 65: Data Table on North America - Market size and forecast 2021-2026 ($ million)
Exhibit 66: Chart on North America - Year-over-year growth 2021-2026 (%)
Exhibit 67: Data Table on North America - Year-over-year growth 2021-2026 (%)

8.4 Europe - Market size and forecast 2021-2026

Exhibit 68: Chart on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 69: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
Exhibit 70: Chart on Europe - Year-over-year growth 2021-2026 (%)
Exhibit 71: Data Table on Europe - Year-over-year growth 2021-2026 (%)

8.5 Asia - Market size and forecast 2021-2026

Exhibit 72: Chart on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 73: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
Exhibit 74: Chart on Asia - Year-over-year growth 2021-2026 (%)
Exhibit 75: Data Table on Asia - Year-over-year growth 2021-2026 (%)

8.6 Rest of World (ROW) - Market size and forecast 2021-2026

Exhibit 76: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 77: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
Exhibit 78: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
Exhibit 79: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

8.7 US - Market size and forecast 2021-2026

Exhibit 80: Chart on US - Market size and forecast 2021-2026 ($ million)
Exhibit 81: Data Table on US - Market size and forecast 2021-2026 ($ million)
Exhibit 82: Chart on US - Year-over-year growth 2021-2026 (%)
Exhibit 83: Data Table on US - Year-over-year growth 2021-2026 (%)

8.8 Germany - Market size and forecast 2021-2026

Exhibit 84: Chart on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 85: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
Exhibit 86: Chart on Germany - Year-over-year growth 2021-2026 (%)
Exhibit 87: Data Table on Germany - Year-over-year growth 2021-2026 (%)

8.9 Canada - Market size and forecast 2021-2026

Exhibit 88: Chart on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 89: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
Exhibit 90: Chart on Canada - Year-over-year growth 2021-2026 (%)
Exhibit 91: Data Table on Canada - Year-over-year growth 2021-2026 (%)

8.10 China - Market size and forecast 2021-2026

Exhibit 92: Chart on China - Market size and forecast 2021-2026 ($ million)
Exhibit 93: Data Table on China - Market size and forecast 2021-2026 ($ million)
Exhibit 94: Chart on China - Year-over-year growth 2021-2026 (%)
Exhibit 95: Data Table on China - Year-over-year growth 2021-2026 (%)

8.11 France - Market size and forecast 2021-2026

Exhibit 96: Chart on France - Market size and forecast 2021-2026 ($ million)
Exhibit 97: Data Table on France - Market size and forecast 2021-2026 ($ million)
Exhibit 98: Chart on France - Year-over-year growth 2021-2026 (%)
Exhibit 99: Data Table on France - Year-over-year growth 2021-2026 (%)

8.12 Market opportunity by geography

Exhibit 100: Market opportunity by geography ($ million)

9 Drivers, Challenges, and Trends

9.1 Market drivers

9.2 Market challenges

9.3 Impact of drivers and challenges

Exhibit 101: Impact of drivers and challenges in 2021 and 2026

9.4 Market trends

10 Vendor Landscape

10.1 Overview

10.2 Vendor landscape

Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

10.3 Landscape disruption

Exhibit 103: Overview on factors of disruption

10.4 Industry risks

Exhibit 104: Impact of key risks on business

11 Vendor Analysis

11.1 Vendors covered

Exhibit 105: Vendors covered

11.2 Market positioning of vendors

Exhibit 106: Matrix on vendor position and classification

11.3 Abbott Laboratories

Exhibit 107: Abbott Laboratories - Overview
Exhibit 108: Abbott Laboratories - Business segments
Exhibit 109: Abbott Laboratories - Key news
Exhibit 110: Abbott Laboratories - Key offerings
Exhibit 111: Abbott Laboratories - Segment focus

11.4 bioMerieux SA

Exhibit 112: bioMerieux SA - Overview
Exhibit 113: bioMerieux SA - Business segments
Exhibit 114: bioMerieux SA - Key offerings
Exhibit 115: bioMerieux SA - Segment focus

11.5 Danaher Corp.

Exhibit 116: Danaher Corp. - Overview
Exhibit 117: Danaher Corp. - Business segments
Exhibit 118: Danaher Corp. - Key news
Exhibit 119: Danaher Corp. - Key offerings
Exhibit 120: Danaher Corp. - Segment focus

11.6 F. Hoffmann La Roche Ltd.

Exhibit 121: F. Hoffmann La Roche Ltd. - Overview
Exhibit 122: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 123: F. Hoffmann La Roche Ltd. - Key news
Exhibit 124: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 125: F. Hoffmann La Roche Ltd. - Segment focus

11.7 QIAGEN NV

Exhibit 126: QIAGEN NV - Overview
Exhibit 127: QIAGEN NV - Product / Service
Exhibit 128: QIAGEN NV - Key news
Exhibit 129: QIAGEN NV - Key offerings

11.8 QuantuMDx Group Ltd.

Exhibit 130: QuantuMDx Group Ltd. - Overview
Exhibit 131: QuantuMDx Group Ltd. - Product / Service
Exhibit 132: QuantuMDx Group Ltd. - Key offerings

11.9 Quidel Corp.

Exhibit 133: Quidel Corp. - Overview
Exhibit 134: Quidel Corp. - Product / Service
Exhibit 135: Quidel Corp. - Key offerings

11.10 Robert Bosch GmbH

Exhibit 136: Robert Bosch GmbH - Overview
Exhibit 137: Robert Bosch GmbH - Business segments
Exhibit 138: Robert Bosch GmbH - Key news
Exhibit 139: Robert Bosch GmbH - Key offerings
Exhibit 140: Robert Bosch GmbH - Segment focus

11.11 Siemens AG

Exhibit 141: Siemens AG - Overview
Exhibit 142: Siemens AG - Business segments
Exhibit 143: Siemens AG - Key news
Exhibit 144: Siemens AG - Key offerings
Exhibit 145: Siemens AG - Segment focus

11.12 Thermo Fisher Scientific Inc.

Exhibit 146: Thermo Fisher Scientific Inc. - Overview
Exhibit 147: Thermo Fisher Scientific Inc. - Business segments
Exhibit 148: Thermo Fisher Scientific Inc. - Key news
Exhibit 149: Thermo Fisher Scientific Inc. - Key offerings
Exhibit 150: Thermo Fisher Scientific Inc. - Segment focus

12 Appendix

12.1 Scope of the report

12.2 Inclusions and exclusions checklist

Exhibit 151: Inclusions checklist
Exhibit 152: Exclusions checklist

12.3 Currency conversion rates for US$

Exhibit 153: Currency conversion rates for US$

12.4 Research methodology

Exhibit 154: Research methodology
Exhibit 155: Validation techniques employed for market sizing
Exhibit 156: Information sources

12.5 List of abbreviations

Exhibit 157: List of abbreviations

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact Us:

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio